Vertex Pharmaceuticals Inc - VRTX

Syros Pharmaceuticals Appoints Eric R. Olson, Ph.D. as Chief Scientifi... 22 May 2013 - Business Wire

Medivir: Primary efficacy and safety findings from phase III study of ... 21 May 2013 - Business Wire

Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's S... 21 May 2013 - PR Newswire

Tens of Thousands to Walk for a Cure for Cystic Fibrosis 17 May 2013 - PR Newswire

Vertex Calls for Redemption of $400 Million in Convertible Senior Subo... 17 May 2013 - Business Wire

Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two ... 09 May 2013 - Business Wire

Lux Capital Adds Bilal Zuberi as Partner 09 May 2013 - Business Wire

Vertex Reports First Quarter 2013 Financial Results and Reviews Recent... 30 Apr 2013 - Business Wire

Vertex Announces New Data that Showed High Viral Cure Rates with a Tot... 24 Apr 2013 - Business Wire

Netflix Indicating Big Jump Pre-Market on Earnings Surprise - Top Earn... 23 Apr 2013 - PR Newswire

ALS-2200 (VX-135) Viral Kinetic Study Shows Significant Reduction in H... 23 Apr 2013 - Business Wire

Medivir: New Data from Simeprevir Phase III Studies Quest 1 and 2 in H... 23 Apr 2013 - Business Wire

Findings from Two Phase 3 Studies of Janssen's Simeprevir Administered... 23 Apr 2013 - PR Newswire

Vertex Pharmaceuticals Inc (VRTX :)